Newspaper article from our research archive:

Shire Development.(DDMAC)

Wayne, PA, May 1 (DDMAC)

The Division of Drug Marketing, Advertising, and Communications (DDMAC) reviewed a Notebook (FOS1598) and a Medical Exam Light Case (FOS1597) submitted by Shire Development for Fosrenol (lanthanum carbonate) and determined the items violative "because although they have the form of reminder labeling," which is exempted by regulation from the requirements for the disclosure of risk and other information, "we have determined that your promotional materials are not appropriate reminder labeling."

Therefore, the pieces misbrand Fosrenol in violation of regulations because they fail to include the drug product's indication, as well as contextual ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!